Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Survival advantage for etoposide/cisplatin over paclitaxel/carboplatin concurrent chemoradiation in patients with inoperable stage III NSCLC: a subgroup analysis for ECOG 2 patients would be of great interest.

Literature DB >> 28911081

Survival advantage for etoposide/cisplatin over paclitaxel/carboplatin concurrent chemoradiation in patients with inoperable stage III NSCLC: a subgroup analysis for ECOG 2 patients would be of great interest.

F Manapov¹, C Eze¹.

Abstract

Entities: Chemical Species

Mesh：

Substances：

Year: 2017 PMID： 28911081 DOI： 10.1093/annonc/mdx254

Source DB: PubMed Journal: Ann Oncol ISSN： 0923-7534 Impact factor: 32.976

Keyword Cloud
Cited

× No keyword cloud information.

1 in total

1. Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancer.

Authors: Olarn Roengvoraphoj; Cherylina Wijaya; Chukwuka Eze; Minglun Li; Maurice Dantes; Julian Taugner; Amanda Tufman; Rudolf Maria Huber; Claus Belka; Farkhad Manapov
Journal: Strahlenther Onkol Date: 2017-11-07 Impact factor: 3.621

1 in total